Commure Acquires Augmedix (AUGX) for $139 Million at $2.35/Share

Jul 19, 2024, 12:55 PM

Commure, Inc. has announced its acquisition of Augmedix, Inc. (NASDAQ: AUGX) for $2.35 per share in cash, valuing the deal at $139 million. The acquisition represents a 155.4% premium over Augmedix's previous share price. Augmedix, known for its AI-powered medical documentation solutions, aims to enhance its ambient documentation capabilities and bring more innovation to clinicians and health systems through this merger. This acquisition follows Commure's recent merger with Athelas into a $6 billion enterprise in late 2023. The deal is expected to close by July 25, with a tender offer expiring on Aug 15.